Company Profiles

driven by the PitchBook Platform

Avaxia

Description

Developer of orally delivered antibody therapeutics. The company is pursuing products for oral mucositis, inflammatory bowel disease, diabetes and obesity.

2005

Founded

PRIVATE

Status

11-50

Employees

2ndary - Private

Latest Deal Type

$23.7M

Total Amount Raised

15

Investors

Description

Developer of orally delivered antibody therapeutics. The company is pursuing products for oral mucositis, inflammatory bowel disease, diabetes and obesity.

Website:

www.avaxiabiologics.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Delivery

Other Industries

Biotechnology

Primary Office

128 Spring Street Suite 620 Lexington, MA 02421United States +1 (781) 861-0062
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Avaxia's full profile, request a free trial.

Avaxia Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Avaxia Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Avaxia Investors (15)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Ariel Southeast Angel PartnersAngel GroupMinority000 0000000 0000
Beacon AngelsVenture CapitalMinority000 0000000 0000
Beta FundVenture CapitalMinority000 0000000 0000
Boston Harbor AngelsAngel GroupMinority000 0000000 0000
Cherrystone Angel GroupAngel GroupMinority000 0000000 0000
Ariel Southeast Angel Partners Angel Group
Beacon Angels Venture Capital
Beta Fund Venture Capital
Boston Harbor Angels Angel Group
Cherrystone Angel Group Angel Group

Avaxia Executive Team (5)

NameTitleBoard
Seat
Contact
Info
David Poorvin Ph.DCo-Founder & Board Member
Neil Schauer Ph.DSenior Vice President, Technical Operations
Michael RivardVice President, Corporate Development
Deborah Hartman Ph.DVice President of Research
M. Scott Harris MDChief Medical Officer
David Poorvin Ph.D Co-Founder & Board Member
Neil Schauer Ph.D Senior Vice President, Technical Operations
Michael Rivard Vice President, Corporate Development
Deborah Hartman Ph.D Vice President of Research
M. Scott Harris MD Chief Medical Officer

Avaxia Board Members (6)

NameRepresentingRoleSinceContact
Info
Christopher KiritsySelfChairman000 0000
David Poorvin Ph.DAvaxiaCo-Founder & Board Member000 0000
Henry KaySelfBoard Member000 0000
John EdwardsSelfBoard Member and Senior Business Advisor000 0000
Nada Jain Ph.DGolden SeedsManaging Partner000 0000
Christopher Kiritsy Chairman Self
David Poorvin Ph.D Co-Founder & Board Member Avaxia
Henry Kay Board Member Self
John Edwards Board Member and Senior Business Advisor Self
Nada Jain Ph.D Managing Partner Golden Seeds
Request full access to PitchBook